Franklin Resources’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,626
Closed -$345K 2764
2023
Q3
$345K Buy
18,626
+268
+1% +$3.03K ﹤0.01% 2097
2023
Q2
$203K Buy
18,358
+10,228
+126% +$143K ﹤0.01% 2375
2023
Q1
$109K Buy
8,130
+47
+0.6% +$813 ﹤0.01% 2098
2022
Q4
$100K Buy
8,083
+86
+1% +$1.22K ﹤0.01% 2127
2022
Q3
$111K Buy
7,997
+142
+2% +$2.29K ﹤0.01% 2090
2022
Q2
$108K Sell
7,855
-3,345
-30% -$53.6K ﹤0.01% 2137
2022
Q1
$182K Buy
+11,200
New +$175K ﹤0.01% 2178
2021
Q4
Sell
-2,417
Closed -$36K 2575
2021
Q3
$36K Buy
2,417
+2,137
+763% +$34.2K ﹤0.01% 2390
2021
Q2
$6K Sell
280
-14
-5% -$278 ﹤0.01% 2003
2021
Q1
$7K Sell
294
-578
-66% -$16.1K ﹤0.01% 1968
2020
Q4
$22K Buy
+872
New +$28.9K ﹤0.01% 1867
2019
Q4
Sell
-670,200
Closed -$44.5M 1589
2019
Q3
$44.5M Hold
670,200
0.02% 558
2019
Q2
$53.3M Buy
670,200
+241,700
+56% +$21.6M 0.03% 538
2019
Q1
$47.9M Buy
428,500
+145,200
+51% +$15.9M 0.03% 534
2018
Q4
$28.6M Buy
+283,300
New +$29.4M 0.02% 617
2015
Q4
Sell
-275,991
Closed -$45.8M 1604
2015
Q3
$45.8M Hold
275,991
0.02% 594
2015
Q2
$66.6M Hold
275,991
0.03% 510
2015
Q1
$77.8M Sell
275,991
-314,116
-53% -$68M 0.04% 468
2014
Q4
$92.1M Buy
590,107
+261,350
+79% +$48.3M 0.04% 408
2014
Q3
$77.8M Buy
328,757
+138,657
+73% +$35.4M 0.04% 445
2014
Q2
$45M Buy
190,100
+48,000
+34% +$12.7M 0.02% 640
2014
Q1
$46.9M Buy
+142,100
New +$47.9M 0.02% 601

Franklin Resources's ICPT Position: Q4 2023 in Review

Franklin Resources sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 18,626 shares — an estimated $345K sold.

Franklin Resources first reported a position in ICPT in Q1 2014 and held it in 22 quarters. The position peaked at $92.1M in Q4 2014. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Franklin Resources reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Franklin Resources sold 18,626 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $345K.
  • Franklin Resources first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 22 quarters.
  • Franklin Resources's Intercept Pharmaceuticals, Inc. position peaked at $92.1M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Franklin Resources's 13F filing for Q4 2023, filed 9 Feb 2024.